GBH Openvault

FRONTLINE; Breast Implants on Trial

Part of Frontline.


License Clip

More material may be available from this program at the GBH Archives. If you are a researcher interested in accessing the collection at GBH, please email archive_requests@wgbh.org.

This program has not been digitized yet or cannot be made available on Open Vault.

Series
FRONTLINE
Program
Breast Implants on Trial
Program Number

1412

Series Description

FRONTLINE is investigative journalism that questions, explains and changes our world. Since 1983, FRONTLINE has served as PBS's flagship public affairs series. Hailed upon its television broadcast debut as "the last best hope for broadcast documentaries," FRONTLINE's stature is reaffirmed each week through incisive documentaries covering the scope and complexity of the human experience.

Program Description

Some 450,000 women are part of the proposed global settlement against U.S. breast implant manufacturers in the largest lawsuit in history. Many claim that they have contracted a wide range of silicone-related diseases, but recent medical studies conducted by the nation's premier researchers have failed to find any evidence that silicone breast implants are dangerous. As Congress actively examines the powers of the FDA and the possibilities of tort reform, FRONTLINE looks at the enormous stakes involved in the clash between biomedical science and the nation's most powerful litigators.

Asset Type

Broadcast program

Media Type

Video

Genres
Documentary
Citation
Chicago: “FRONTLINE; Breast Implants on Trial,” GBH Archives, accessed September 21, 2021, http://openvault.wgbh.org/catalog/V_FEB965C678C04F6EB9180788CAC45159.
MLA: “FRONTLINE; Breast Implants on Trial.” GBH Archives. Web. September 21, 2021. <http://openvault.wgbh.org/catalog/V_FEB965C678C04F6EB9180788CAC45159>.
APA: FRONTLINE; Breast Implants on Trial. Boston, MA: GBH Archives. Retrieved from http://openvault.wgbh.org/catalog/V_FEB965C678C04F6EB9180788CAC45159
If you have more information about this item, we want to know! Please contact us, including the URL.